$SEZL
Sezzle Inc. Stock $sezl

$sezl Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000166299123000009 Filed on February 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$34.67M	$38.28M	$125.6M
YoY Change	25.47%	-37.19%	9.37%
Cost Of Revenue	$8.239M	$9.547M	$40.78M
YoY Change	-30.15%	-61.78%	-6.21%
Gross Profit	$26.43M	$28.73M	$84.79M
YoY Change	66.89%	-20.11%	18.86%
Gross Profit Margin	76.24%	75.06%	67.53%
Selling, General & Admin	$2.798M	$22.08M	$16.41M
YoY Change	-63.86%	-70.45%	4.08%
% of Gross Profit	10.59%	76.85%	19.36%
Research & Development			$2.012M
YoY Change			37.62%
% of Gross Profit			2.37%
Depreciation & Amortization	$200.8K	$197.8K	$847.1K
YoY Change	-10.36%	-51.76%	13.08%
% of Gross Profit	0.76%	0.69%	1.0%
Operating Expenses	$2.798M	$23.99M	$18.42M
YoY Change	-63.86%	-69.25%	6.93%
Operating Profit	$5.420M	$4.742M	-$28.43M
YoY Change	-120.75%	-111.28%	-58.6%
Interest Expense	$3.377M	-$3.124M	$8.601M
YoY Change	109.06%	19.2%	63.22%
% of Operating Profit	62.31%	-65.86%
Other Income/Expense, Net	$113.5K	-$149.9K	-$225.6K
YoY Change	-149.7%	86.24%	246.31%
Pretax Income	$1.736M	$655.1K	-$38.02M
YoY Change	-106.21%	-101.46%	-49.38%
Income Tax	$11.62K	$20.82K	$69.45K
% Of Pretax Income	0.67%	3.18%
Net Earnings	$1.725M	$634.3K	-$38.09M
YoY Change	-106.16%	-101.42%	-49.32%
Net Earnings / Revenue	4.97%	1.66%	-30.34%
Basic Earnings Per Share	$0.31		-$0.18
Diluted Earnings Per Share	$0.31	$0.00	-$0.18
COMMON SHARES
Basic Shares Outstanding	208.3M shares	207.9M shares	206.9M shares
Diluted Shares Outstanding	5.557M shares		206.9M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$59.04M	$68.28M	$68.28M
YoY Change	1.14%	-11.31%	-11.31%
Cash & Equivalents	$59.04M	$68.28M	$68.28M
Short-Term Investments
Other Short-Term Assets	$5.267M	$5.961M	$5.961M
YoY Change	-7.59%	13.83%	13.83%
Inventory
Prepaid Expenses
Receivables	$84.78M	$97.43M	$97.43M
Other Receivables	$1.888M	$2.533M	-$1.536M
Total Short-Term Assets	$151.0M	$170.1M	$170.1M
YoY Change	-14.55%	-23.12%	-23.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$271.4K	$281.6K	$368.3K
YoY Change	-55.3%	-57.49%	-61.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$717.0K	$733.9K	$753.9K
YoY Change	193.28%	213.97%	197.11%
Total Long-Term Assets	$2.504M	$2.445M	$2.445M
YoY Change	13.16%	15.73%	15.73%
TOTAL ASSETS
Total Short-Term Assets	$151.0M	$170.1M	$170.1M
Total Long-Term Assets	$2.504M	$2.445M	$2.445M
Total Assets	$153.5M	$172.6M	$172.6M
YoY Change	-14.21%	-22.75%	-22.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.27M	$83.02M	$83.02M
YoY Change	-31.49%	-13.98%	-13.98%
Accrued Expenses	$7.287M	$10.45M	$10.53M
YoY Change	-47.57%	30.66%	28.88%
Deferred Revenue	$1.637M	$1.516M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$77.42M	$99.19M	$99.19M
YoY Change	-32.07%	-7.78%	-7.78%
LONG-TERM LIABILITIES
Long-Term Debt	$58.95M	$64.03M	$64.03M
YoY Change	13.04%	-17.87%	-17.87%
Other Long-Term Liabilities	$2.516M	$511.3K	$511.3K
YoY Change	4593.28%		462.12%
Total Long-Term Liabilities	$2.516M	$64.54M	$64.54M
YoY Change	-95.18%		-17.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$77.42M	$99.19M	$99.19M
Total Long-Term Liabilities	$2.516M	$64.54M	$64.54M
Total Liabilities	$139.8M	$163.7M	$163.7M
YoY Change	-15.86%	-11.79%	-11.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$162.9M	-$165.5M
YoY Change	4.83%	29.9%
Common Stock	$2.084K	$2.083K
YoY Change	0.72%	1.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.66M	$8.843M	$8.843M
YoY Change
Total Liabilities & Shareholders Equity	$153.5M	$172.6M	$172.6M
YoY Change	-14.21%	-22.75%	-22.75%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$1.725M	$634.3K	-$38.09M
YoY Change	-106.16%	-101.42%	-49.32%
Depreciation, Depletion And Amortization	$200.8K	$197.8K	$847.1K
YoY Change	-10.36%	-51.76%	13.08%
Cash From Operating Activities	-$4.075M	$1.441M	$8.512M
YoY Change	-152.18%	-102.17%	-111.8%
INVESTING ACTIVITIES
Capital Expenditures	$51.16K	$221.5K	$52.24K
YoY Change	-9.44%	-129.63%	-92.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$321.3K	-$221.5K	-$1.008M
YoY Change	-14.14%	-70.37%	-29.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$381.4K
YoY Change			-101.39%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$5.281M	9.090M	-$15.69M
YoY Change	-79.84%	-89.5%	-124.81%
NET CHANGE
Cash From Operating Activities	-$4.075M	1.441M	$8.512M
Cash From Investing Activities	-$321.3K	-221.5K	-$1.008M
Cash From Financing Activities	-$5.281M	9.090M	-$15.69M
Net Change In Cash	-$9.677M	10.31M	-$8.184M
YoY Change	-48.44%	-46.5%	-20.64%
FREE CASH FLOW
Cash From Operating Activities	-$4.075M	$1.441M	$8.512M
Capital Expenditures	$51.16K	$221.5K	$52.24K
Free Cash Flow	-$4.126M	$1.219M	$8.460M
YoY Change	-153.22%	-101.85%	-111.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001662991
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	szl	Financing Receivable Installment Payment Plan Interest Free Payment Period FinancingReceivableInstallmentPaymentPlanInterestFreePaymentPeriod	P42D
CY2022	szl	Financing Receivable Installment Payment Plan Installment Period FinancingReceivableInstallmentPaymentPlanInstallmentPeriod	P14D
CY2022	szl	Cash And Cash Equivalents Transaction Settlement Period CashAndCashEquivalentsTransactionSettlementPeriod	P3D
CY2022	szl	Financing Receivable Installment Payment Plan Fee Waiver Period FinancingReceivableInstallmentPaymentPlanFeeWaiverPeriod	P2D
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56267
CY2022	dei	Entity Registrant Name EntityRegistrantName	SEZZLE INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-0971660
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	251 N 1st Avenue
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 200
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
CY2022	dei	Country Region CountryRegion	+1
CY2022	dei	City Area Code CityAreaCode	651
CY2022	dei	Local Phone Number LocalPhoneNumber	504 5402
CY2022	dei	Security12g Title Security12gTitle	Common Stock, par value $0.00001 per share
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	16457265	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	208267933	shares
CY2022	dei	Auditor Firm AuditorFirmId	23
CY2022	dei	Auditor Name AuditorName	Baker Tilly US, LLP
CY2022	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68279539	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76983728	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1223119	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1886440	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	93358404	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	133986583	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2532710	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5084099	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4737688	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3350053	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	170131460	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	221290903	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1322836	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	910584	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	281605	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	662472	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86715	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	285865	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	20000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	20000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	733922	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	233752	usd
CY2022Q4	us-gaap	Assets Assets	172576538	usd
CY2021Q4	us-gaap	Assets Assets	223403576	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	83020739	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	96516668	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79312	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	171959	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10448872	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7996772	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4129371	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2874046	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1516228	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	99194522	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	107559445	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	250000	usd
CY2021Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	250000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	90962	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	1222525	usd
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	1088869	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	63777475	usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	77711131	usd
CY2022Q4	szl	Warrant Liabilities Noncurrent WarrantLiabilitiesNoncurrent	511295	usd
CY2021Q4	szl	Warrant Liabilities Noncurrent WarrantLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Liabilities Liabilities	163733292	usd
CY2021Q4	us-gaap	Liabilities Liabilities	185611538	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	209270070	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	204891057	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	208181834	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	204230939	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2083	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2044	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	179054368	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	168338673	usd
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	0	shares
CY2021Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	20729	shares
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	0	usd
CY2021Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	18545	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1088236	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	660118	shares
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	4072752	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3691322	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-643974	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	563911	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165496479	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127402723	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8843246	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	37792038	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	172576538	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	223403576	usd
CY2022	us-gaap	Revenues Revenues	125570441	usd
CY2021	us-gaap	Revenues Revenues	114816635	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	51217083	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	56831368	usd
CY2022	szl	Transaction Expense TransactionExpense	40776825	usd
CY2021	szl	Transaction Expense TransactionExpense	43476143	usd
CY2022	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	8190022	usd
CY2021	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	5549844	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	18972025	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	9251854	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16411912	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15768583	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	29437179	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	52621682	usd
CY2022	szl	Merger Related Costs Reimbursement Expense Reversal MergerRelatedCostsReimbursementExpenseReversal	11000000	usd
CY2021	szl	Merger Related Costs Reimbursement Expense Reversal MergerRelatedCostsReimbursementExpenseReversal	0	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	154005046	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	183499474	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-28434605	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-68682839	usd
CY2022	us-gaap	Interest Expense InterestExpense	8600716	usd
CY2021	us-gaap	Interest Expense InterestExpense	5269284	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-225606	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-65145	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-813806	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1092679	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-50424	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38024309	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-75109947	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69447	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58416	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-38093756	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-75168363	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1207885	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	69406	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39301641	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-75098957	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	206856959	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	206856959	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	200344028	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	200344028	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	59958417	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9013029	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	765786	usd
CY2021	szl	Stock Issued During Period Value Restricted Stock Units Vested In Period StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod	5148725	usd
CY2021	szl	Adjustments Of Additional Paid In Capital Issuance Of Restricted Stock Units For Settlement Of Accrued Expenses AdjustmentsOfAdditionalPaidInCapitalIssuanceOfRestrictedStockUnitsForSettlementOfAccruedExpenses	1996779	usd
CY2021	szl	Adjustments Of Additional Paid In Capital Issuance Of Restricted Stock Units For Settlement Of Accrued Expenses AdjustmentsOfAdditionalPaidInCapitalIssuanceOfRestrictedStockUnitsForSettlementOfAccruedExpenses	1996779	usd
CY2021	szl	Adjustments To Additional Paid In Capital Conversion Of Liability Classified Incentive Award AdjustmentsToAdditionalPaidInCapitalConversionOfLiabilityClassifiedIncentiveAward	8580123	usd
CY2021	szl	Adjustments To Additional Paid In Capital Conversion Of Liability Classified Incentive Award AdjustmentsToAdditionalPaidInCapitalConversionOfLiabilityClassifiedIncentiveAward	8580123	usd
CY2021	szl	Stock Issued During Period Value Stock Subscriptions Collectable On Options Exercised StockIssuedDuringPeriodValueStockSubscriptionsCollectableOnOptionsExercised	0	usd
CY2021	szl	Stock Issued During Period Value Stock Subscriptions Collected On Options Exercised StockIssuedDuringPeriodValueStockSubscriptionsCollectedOnOptionsExercised	246999	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2816095	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	29997232	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	69406	usd
CY2022	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-10590769	usd
CY2021	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	105950424	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-75168363	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	37792038	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	37792038	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7674265	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	100370	usd
CY2022	szl	Stock Issued During Period Value Restricted Stock Units Vested In Period StockIssuedDuringPeriodValueRestrictedStockUnitsVestedInPeriod	2635270	usd
CY2022	szl	Stock Issued During Period Value Stock Subscriptions Collectable On Options Exercised StockIssuedDuringPeriodValueStockSubscriptionsCollectableOnOptionsExercised	0	usd
CY2022	szl	Stock Issued During Period Value Stock Subscriptions Collected On Options Exercised StockIssuedDuringPeriodValueStockSubscriptionsCollectedOnOptionsExercised	324378	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	381434	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1207885	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-38093756	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8843246	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-38093756	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-75168363	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	847126	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	749111	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	29437179	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	52621682	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	9257284	usd
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	7349852	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	10309535	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	14161754	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	983745	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	689930	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	39512	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	5475	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-50424	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-813806	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1092679	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-79683	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	6710739	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	11031826	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1353026	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1855206	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12928944	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	35696079	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1281500	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2111082	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2476822	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7416249	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1516228	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	15548	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-20124	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8511848	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-72132050	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52236	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	686032	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	955841	usd
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	733995	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1008077	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1420027	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1220332	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	71155556	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	174666667	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	84955556	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	135866667	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1330901	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1697705	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	600307	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1000000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100370	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	765786	usd
CY2022	szl	Proceeds From Collection Of Stock Subscriptions Related To Stock Option Exercises ProceedsFromCollectionOfStockSubscriptionsRelatedToStockOptionExercises	324378	usd
CY2021	szl	Proceeds From Collection Of Stock Subscriptions Related To Stock Option Exercises ProceedsFromCollectionOfStockSubscriptionsRelatedToStockOptionExercises	246999	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	381434	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2652014	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2768	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15687894	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63239966	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1183387	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98376	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8184123	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10312111	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78890168	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89103903	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69522658	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78890168	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8005	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	328341	usd
CY2022	szl	Issuance Of Restricted Stock Units For Settlement Of Accrued Expenses IssuanceOfRestrictedStockUnitsForSettlementOfAccruedExpenses	0	usd
CY2021	szl	Issuance Of Restricted Stock Units For Settlement Of Accrued Expenses IssuanceOfRestrictedStockUnitsForSettlementOfAccruedExpenses	1996779	usd
CY2022	szl	Conversion Of Liability Classified Incentive Award ConversionOfLiabilityClassifiedIncentiveAward	0	usd
CY2021	szl	Conversion Of Liability Classified Incentive Award ConversionOfLiabilityClassifiedIncentiveAward	8580123	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	164081	usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	561719	usd
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	7790430	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	4819604	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	65395	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	56017	usd
CY2022Q4	szl	Financing Receivable Installment Payment Plan Number Of Installments FinancingReceivableInstallmentPaymentPlanNumberOfInstallments	4	installment
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose us to concentrations of credit risk consist primarily of cash and cash equivalents. We maintain our cash in depository accounts that, at times, may exceed limits established by the Federal Deposit Insurance Corporation (“FDIC”) and equivalent foreign institutions. As of the date of this report, we have not experienced losses on such accounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Foreign Currency Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold funds and settle payments that are denominated in currencies other than U.S. dollars. Changes in foreign currency exchange rates expose us to fluctuations on our consolidated balance sheets and statements of operations and comprehensive loss. Currency risk is managed through limits set on total foreign deposits on hand that we routinely monitor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Notes Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk of credit losses as a result of extending credit to consumers. Changes in economic conditions may result in higher credit losses. We have a policy for establishing credit lines for individual consumers that helps mitigate credit risk. The allowance for uncollectible accounts is adequate for covering any potential losses on outstanding notes receivable.</span></div>
CY2022Q4	szl	Financing Receivable Installment Payment Plan Number Of Installments FinancingReceivableInstallmentPaymentPlanNumberOfInstallments	4	installment
CY2022Q4	szl	Capitalization Policy Threshold CapitalizationPolicyThreshold	1000	usd
CY2022Q4	szl	Capitalization Policy Threshold CapitalizationPolicyThreshold	1000	usd
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2012000	usd
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	1462000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	18476899	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	8569276	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements. Our estimates and judgments are based on historical experience and various other assumptions that we believe are reasonable under the circumstances. The amount of assets and liabilities reported on our consolidated balance sheets and the amounts of income and expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, determining the allowance for uncollectible accounts recorded against outstanding receivables, the valuation of equity based compensation, and income taxes.</span></div>
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-118831	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-69228	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1207885	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	69406	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform with the current period presentation format. These reclassifications had no effect on our net loss or total comprehensive loss.</span></div>
CY2022	us-gaap	Revenues Revenues	125570441	usd
CY2021	us-gaap	Revenues Revenues	114816635	usd
CY2022	us-gaap	Revenues Revenues	125570441	usd
CY2021	us-gaap	Revenues Revenues	114816635	usd
CY2022	us-gaap	Revenue Not From Contract With Customer Excluding Interest Income RevenueNotFromContractWithCustomerExcludingInterestIncome	11959044	usd
CY2021	us-gaap	Revenue Not From Contract With Customer Excluding Interest Income RevenueNotFromContractWithCustomerExcludingInterestIncome	206860	usd
CY2022Q4	us-gaap	Financing Receivable Deferred Income FinancingReceivableDeferredIncome	4068332	usd
CY2021Q4	us-gaap	Financing Receivable Deferred Income FinancingReceivableDeferredIncome	5240919	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1516228	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	107650187	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	162341675	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	23114173	usd
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11133146	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	29437179	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	52621682	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	5040041	usd
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	6153728	usd
CY2022	szl	Financing Receivable Allowance For Credit Loss Write Off Net FinancingReceivableAllowanceForCreditLossWriteOffNet	42327901	usd
CY2021	szl	Financing Receivable Allowance For Credit Loss Write Off Net FinancingReceivableAllowanceForCreditLossWriteOffNet	40640655	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10223451	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	23114173	usd
CY2022Q4	szl	Financing Receivable After Allowance For Credit Loss Before Deferred Income FinancingReceivableAfterAllowanceForCreditLossBeforeDeferredIncome	97426736	usd
CY2021Q4	szl	Financing Receivable After Allowance For Credit Loss Before Deferred Income FinancingReceivableAfterAllowanceForCreditLossBeforeDeferredIncome	139227502	usd
CY2022Q4	us-gaap	Financing Receivable Deferred Income FinancingReceivableDeferredIncome	4068332	usd
CY2021Q4	us-gaap	Financing Receivable Deferred Income FinancingReceivableDeferredIncome	5240919	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	93358404	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	133986583	usd
CY2022	szl	Note Receivable Weighted Average Days Outstanding NoteReceivableWeightedAverageDaysOutstanding	P34D
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	107650187	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10223451	usd
CY2022Q4	szl	Financing Receivable After Allowance For Credit Loss Before Deferred Income FinancingReceivableAfterAllowanceForCreditLossBeforeDeferredIncome	97426736	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	162341675	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	23114173	usd
CY2021Q4	szl	Financing Receivable After Allowance For Credit Loss Before Deferred Income FinancingReceivableAfterAllowanceForCreditLossBeforeDeferredIncome	139227502	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2532710	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5084099	usd
CY2022	szl	Allowance For Credit Loss Receivable Other Current Recoveries AllowanceForCreditLossReceivableOtherCurrentRecoveries	1252437	usd
CY2021	szl	Allowance For Credit Loss Receivable Other Current Recoveries AllowanceForCreditLossReceivableOtherCurrentRecoveries	1273319	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	83020739	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	96516668	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2550420	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1657637	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1227584	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	747053	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1322836	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	910584	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	503907	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	355043	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-32493098	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-63143175	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5531211	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-11966772	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38024309	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-75109947	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	69447	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	58416	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69447	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58416	usd
CY2022	szl	Operating Losses Carryforward Term OperatingLossesCarryforwardTerm	P15Y
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25459247	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17865584	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3389435	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6171512	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1322642	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3273873	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	216391	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2022Q4	szl	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	17575	usd
CY2021Q4	szl	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	50408	usd
CY2022Q4	szl	Deferred Tax Assets Startup Costs DeferredTaxAssetsStartupCosts	9514	usd
CY2021Q4	szl	Deferred Tax Assets Startup Costs DeferredTaxAssetsStartupCosts	10517	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	458609	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	328154	usd
CY2022Q4	szl	Deferred Tax Assets Tax Deferred Expense Nondeductible Interest DeferredTaxAssetsTaxDeferredExpenseNondeductibleInterest	3816974	usd
CY2021Q4	szl	Deferred Tax Assets Tax Deferred Expense Nondeductible Interest DeferredTaxAssetsTaxDeferredExpenseNondeductibleInterest	945153	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	365743	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	290029	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35056130	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	28935230	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34868210	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28842025	usd
CY2022Q4	szl	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	168505	usd
CY2021Q4	szl	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	36457	usd
CY2022Q4	szl	Deferred Tax Liabilities Equity Based Compensation DeferredTaxLiabilitiesEquityBasedCompensation	0	usd
CY2021Q4	szl	Deferred Tax Liabilities Equity Based Compensation DeferredTaxLiabilitiesEquityBasedCompensation	356	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	19415	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	56392	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	187920	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	93205	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.026
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.026
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.097
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.012
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.005
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.159
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.235
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.013
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34868210	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6026000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	17615000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022	szl	Other Commitment Term Of Agreement OtherCommitmentTermOfAgreement	P2Y
CY2022Q4	us-gaap	Other Commitment OtherCommitment	6100000	usd
CY2021Q4	us-gaap	Other Commitment OtherCommitment	6700000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1088236	shares
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	4072752	usd
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	660118	shares
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3691322	usd
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1683397	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.71
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10309535	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14161754	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21195768	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.74
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23079520	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M3D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	395313	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.73
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3029480	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2383405	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	7288982	shares
CY2022	szl	Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice	2.59
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11272619	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.56
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	686035	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9656457	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.30
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	685914	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1616162	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.10
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	121	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y7M9D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24515544	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.34
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	84731639	usd
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1922480	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.29
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8329397	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3558859	shares
CY2021	szl	Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice	2.37
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21195768	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.74
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23079520	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M3D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11137578	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.02
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16036993	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	10058190	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.55
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	7042527	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y6M18D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.06
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	9984655	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	27266222	usd
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2021Q1	szl	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Percentage Of Individual Salary ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodPercentageOfIndividualSalary	2
CY2021Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	8.00
CY2022	szl	Adjustments To Additional Paid In Capital Conversion Of Liability Classified Incentive Award AdjustmentsToAdditionalPaidInCapitalConversionOfLiabilityClassifiedIncentiveAward	8580123	usd
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1455004	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	588612	usd
CY2022Q3	szl	Proceeds From Termination Of Business Acquisition ProceedsFromTerminationOfBusinessAcquisition	11000000	usd

Files In Submission

Name	View Source	Status
0001662991-23-000009-index-headers.html	Edgar Link	pending
0001662991-23-000009-index.html	Edgar Link	pending
0001662991-23-000009.txt	Edgar Link	pending
0001662991-23-000009-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
szl-20221231.htm	Edgar Link	pending
szl-20221231.xsd	Edgar Link	pending
szl-20221231_g1.jpg	Edgar Link	pending
szl-20221231_g2.jpg	Edgar Link	pending
szl-20221231_cal.xml	Edgar Link	unprocessable
szl-20221231_def.xml	Edgar Link	unprocessable
szl-20221231_pre.xml	Edgar Link	unprocessable
szl-20221231_lab.xml	Edgar Link	unprocessable
szl-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SEZL
Sezzle Inc. Stock $sezl

2023 Q1 Form 10-K Financial Statement

#000166299123000009 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEZL Sezzle Inc. Stock $sezl

2023 Q1 Form 10-K Financial Statement

#000166299123000009 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEZL
Sezzle Inc. Stock $sezl